30 Day FRN

0013 30 day notice publication.pdf

Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes Pursuant to 21 U.S.C. 952

30 Day FRN

OMB: 1117-0013

Document [pdf]
Download: pdf | pdf
lotter on DSK11XQN23PROD with NOTICES1

78788

Federal Register / Vol. 88, No. 220 / Thursday, November 16, 2023 / Notices

Drug Enforcement Administration;
Mailing Address: 8701 Morrissette
Drive, Springfield, Virginia 22152;
Telephone: (571) 362–3261, email:
[email protected].
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Written comments and
recommendations for this information
collection should be submitted within
30 days of the publication of this notice
on the following website
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function and entering either the title of
the information collection or the OMB
Control Number 1117–0023. This
information collection request may be
viewed at www.reginfo.gov. Follow the
instructions to view Department of
Justice, information collections
currently under review by OMB.
DOJ seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOJ notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a currently approved
collection.

VerDate Sep<11>2014

17:01 Nov 15, 2023

Jkt 262001

2. Title of the Form/Collection:
Import/Export Declaration for List I and
List II Chemicals.
3. Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: DEA Forms: 486, 486A. The
applicable component within the
Department of Justice is the Drug
Enforcement Administration, Diversion
Control Division.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: Affected public (Primary):
Business or other for-profit. Affected
public (Other): Not-for-profit
institutions; Federal, State, local, and
tribal governments.
Abstract: Section 1018 of the
Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 971) and
Title 21 Code of Federal Regulations (21
CFR) Part 1313 require any persons who
import, export, or conduct international
transactions involving list I and list II
chemicals are required to establish a
system of recordkeeping and report
certain information regarding those
transactions to DEA. The chemicals
subject to control are used in the
clandestine manufacture of controlled
substances. The reports of domestic,
import, and export regulated
transactions in listed chemicals are
submitted electronically through the
Diversion Control Division secure
network application. Any person who
desires to import non-narcotic
substances in schedules III, IV, and V
must electronically file their return
information. Any person who desires to
export non-narcotic substances in
schedules III and IV and any other
substance in schedule V is also required
to electronically file a controlled
substances import declaration/
controlled substance export invoice.
5. Obligation to Respond: Mandatory
per 21 CFR 1313.
6. Total Estimated Number of
Respondents: 631.
7. Estimated Time per Respondent: 11
minutes for DEA–486 Import, DEA–486
International, and DEA–486A Import,
and 12 minutes for DEA–486 Export.
8. Frequency: 1 for DEA–486 Import
and DEA–486A Import, 4 for DEA–486
International, and 77 for DEA–486
Export.
9. Total Estimated Annual Time
Burden: Ex: 4,134 hours.
10. Total Estimated Annual Other
Costs Burden: $0.
If additional information is required,
contact: Darwin Arceo, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
United States Department of Justice,

PO 00000

Frm 00071

Fmt 4703

Sfmt 4703

Two Constitution Square, 145 N Street
NE, 4W–218 Washington, DC 20530.
Dated: November 7, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2023–25326 Filed 11–15–23; 8:45 am]
BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE
[OMB Number 1117–0013]

Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Application
for Permit To Import Controlled
Substances for Domestic and/or
Scientific Purposes
Drug Enforcement
Administration, Department of Justice.
ACTION: 30-Day notice.
AGENCY:

SUMMARY: The Drug Enforcement
Administration (DEA), Department of
Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. This proposed
information collection was previously
published in the Federal Register on
September 11, 2023, allowing for a 60day comment period.
DATES: Comments are encouraged and
will be accepted for 30 days until
December 18, 2023.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Scott A. Brinks, Regulatory
Drafting and Policy Support Section,
Drug Enforcement Administration;
Mailing Address: 8701 Morrissette
Drive, Springfield, Virginia 22152;
Telephone: (571) 362–3261, email:
[email protected].
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the

E:\FR\FM\16NON1.SGM

16NON1

Federal Register / Vol. 88, No. 220 / Thursday, November 16, 2023 / Notices
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.

lotter on DSK11XQN23PROD with NOTICES1

Written comments and
recommendations for this information
collection should be submitted within
30 days of the publication of this notice
on the following website
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function and entering either the title of
the information collection or the OMB
Control Number 1117–0013. This
information collection request may be
viewed at www.reginfo.gov. Follow the
instructions to view Department of
Justice, information collections
currently under review by OMB.
DOJ seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
cannot be for more than three (3) years
without renewal. The DOJ notes that
information collection requirements
submitted to the OMB for existing ICRs
receive a month-to-month extension
while they undergo review.

desires to import controlled substances
listed in schedules I or II, any narcotic
substance listed in schedules III or IV,
or any non-narcotic substance in
schedule III which the Administrator
has specifically designated by regulation
in section1312.30, or any nonnarcotic
substance in schedule IV or V which is
also listed in schedule I or II of the
Convention on Psychotropic
Substances, must have an import
permit. To obtain the permit to import
controlled substances for domestic and
or scientific purposes, an application for
the permit must be made to DEA on
DEA Form 357.
5. Obligation to Respond: Mandatory
per 21 CFR 1312.11
6. Total Estimated Number of
Respondents: 124.
7. Estimated Time per Respondent:
0.26 minutes.
8. Frequency: 9.
9. Total Estimated Annual Time
Burden: 264.35 hours.
10. Total Estimated Annual Other
Costs Burden: $0.
If additional information is required,
contact: Darwin Arceo, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
United States Department of Justice,
Two Constitution Square, 145 N Street
NE, 4W–218 Washington, DC 20530.
Dated: November 8, 2023.
Darwin Arceo,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2023–25325 Filed 11–15–23; 8:45 am]
BILLING CODE 4410–09–P

DEPARTMENT OF JUSTICE

Overview of This Information
Collection

[OMB Number 1117–0004]

1. Type of Information Collection:
Extension of a currently approved
collection.
2. Title of the Form/Collection:
Controlled Substances Import/Export
Declaration.
3. Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Application for Permit to
Import Controlled Substances for
Domestic and/or Scientific Purposes
Pursuant to 21 U.S.C. 952.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract: Affected public (Primary):
Business or other for-profit.
Abstract: Section 1002 of the
Controlled Substances Import and
Export Act (CSIEA) (21 U.S.C. 952) and
Title 21, Code of Federal Regulations
(21 CFR), Sections 1312.11, 1312.12 and
1312.13 requires any person who

Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Application
for Permit To Export Controlled
Substances, Application for Permit To
Export Controlled Substances for
Subsequent Reexport

VerDate Sep<11>2014

17:01 Nov 15, 2023

Jkt 262001

Drug Enforcement
Administration, Department of Justice.
ACTION: 30-Day notice.
AGENCY:

SUMMARY: The Drug Enforcement
Administration (DEA), Department of
Justice (DOJ), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. This proposed
information collection was previously
published in the Federal Register on
September 11, 2023, allowing for a 60day comment period.

PO 00000

Frm 00072

Fmt 4703

Sfmt 4703

78789

Comments are encouraged and
will be accepted for 30 days until
December 18, 2023.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Scott A. Brinks, Regulatory
Drafting and Policy Support Section,
Drug Enforcement Administration;
Mailing Address: 8701 Morrissette
Drive, Springfield, Virginia 22152;
Telephone: (571) 362–3261, email:
[email protected].
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Written comments and
recommendations for this information
collection should be submitted within
30 days of the publication of this notice
on the following website
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function and entering either the title of
the information collection or the OMB
Control Number 1117–0004. This
information collection request may be
viewed at www.reginfo.gov. Follow the
instructions to view Department of
Justice, information collections
currently under review by OMB.
DOJ seeks PRA authorization for this
information collection for three (3)
years. OMB authorization for an ICR
DATES:

E:\FR\FM\16NON1.SGM

16NON1


File Typeapplication/pdf
File Modified2023-11-16
File Created2023-11-16

© 2024 OMB.report | Privacy Policy